Fig. 2From: Outcome of adult patients with JIA treated with the biosimilar Benepali®: results of the biologic register JuMBOA–F A Course of cJADAS-10, B Physician Global Assessment (PhGA), C Number of joints with active arthritis, D Patients overall well-being (NRS 0-10), E Pain (NRS 0-19), and F HAQ values over time (predicted means with 95% confidence intervals estimated by generalized linear mixed models, p-value for change in parameters over 24 months)Back to article page